Combination Immunotherapy of Primary Prostate Cancer in a Transgenic Mouse Model Using CTLA-4 Blockade1 (original) (raw)
Combination Immunotherapy of Primary Prostate Cancer in a Transgenic Mouse Model Using CTLA-4 …
Tan Sang Truong
Cancer Research, 2000
View PDFchevron_right
Synergistic antitumor effect of chemotactic-prostate tumor-associated antigen gene-modified tumor cell vaccine and anti-CTLA-4 mAb in murine tumor model
Wenbo Ma
Immunology Letters, 2007
View PDFchevron_right
Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages
W. Martin Kast
Vaccine, 2009
View PDFchevron_right
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis
Giordano Nicoletti
International Journal of Cancer, 2007
View PDFchevron_right
Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF
Lawrence Fong
Cancer Research, 2009
View PDFchevron_right
Diversity of Antigen-Specific Responses Induced In Vivo with CTLA-4 Blockade in Prostate Cancer Patients
Lawrence Fong
The Journal of Immunology, 2012
View PDFchevron_right
Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens
Masoud Manjili
Cancer Immunology, Immunotherapy, 2011
View PDFchevron_right
Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy
Matteo Bellone
Cancer Immunology, Immunotherapy, 2012
View PDFchevron_right
Vaccine-Instructed Intratumoral IFN-γ Enables Regression of Autochthonous Mouse Prostate Cancer in Allogeneic T-Cell Transplantation
Matteo Bellone
Cancer Research, 2013
View PDFchevron_right
The Current and Emerging Role of Immunotherapy in Prostate Cancer
James Gulley
Clinical Genitourinary Cancer, 2010
View PDFchevron_right
In vivo Effects of Vaccination with Six-Transmembrane Epithelial Antigen of the Prostate: A Candidate Antigen for Treating Prostate Cancer
Luz García
Cancer Research, 2007
View PDFchevron_right
Immunotherapy: Shifting the Balance of Cell-Mediated Immunity and Suppression in Human Prostate Cancer
James Gulley
Cancers, 2012
View PDFchevron_right
Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity
Martin Kast
Cancer Research, 2008
View PDFchevron_right
Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer
Sol Kim
Prostate, 2009
View PDFchevron_right
Development of Novel Immune Interventions for Prostate Cancer
Neeraj Agarwal
Clinical Genitourinary Cancer, 2012
View PDFchevron_right
Immunotherapy of Prostate Cancer
Marc Schmitz
European Urology, 2008
View PDFchevron_right
In vivoEffects of Vaccination with Six-Transmembrane Epithelial Antigen of the Prostate: A Candidate Antigen for Treating Prostate Cancer
Martin Kast
Cancer Research, 2007
View PDFchevron_right
Therapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advances
James Gulley
Therapeutic advances in vaccines, 2014
View PDFchevron_right
Immunotherapy for Prostate Cancer: What's the Future?
James Gulley
Hematology/Oncology Clinics of North America, 2006
View PDFchevron_right
Immune rejection in a humanized model of murine prostate cancer
William Mcbride
Anticancer research, 2010
View PDFchevron_right
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
Lawrence Fong
Proceedings of the National Academy of Sciences, 2008
View PDFchevron_right
Formulation of the bivalent prostate cancer vaccine with surgifoam elicits antigen-specific effector T cells in PSA-transgenic mice
Syed Shah
View PDFchevron_right
Rapid tolerization of virus-activated tumor-specific CD8 + T cells in prostate tumors of TRAMP mice
Jianzhu Chen
Proceedings of the National Academy of Sciences, 2008
View PDFchevron_right
Challenges in Manipulating Immune System to Treat Prostate Cancer
Ana Frobe
PubMed, 2019
View PDFchevron_right
CD8+ T-cell Responses Rapidly Select for Antigen-Negative Tumor Cells in the Prostate
Jianzhu Chen
2013
View PDFchevron_right
Prostate Tumor Microenvironment Alters Immune Cells and Prevents Long-Term Survival in an Orthotopic Mouse Model Following flt3-Ligand/CD40-Ligand Immunotherapy
Richard Ciavarra
Journal of Immunotherapy, 2004
View PDFchevron_right
Therapeutic cancer vaccine fulfills the promise of immunotherapy in prostate cancer
James Gulley
Immunotherapy, 2011
View PDFchevron_right
Altered Immunity Accompanies Disease Progression in a Mouse Model of Prostate Dysplasia
Amy Tien
2005
View PDFchevron_right
Running Title: Selection of Antigen-negative Tumor Cells in the Prostate
Jianzhu Chen
2016
View PDFchevron_right
Induction of Immunity to Prostate Cancer Antigens: Results of a Clinical Trial of Vaccination with Irradiated Autologous Prostate Tumor Cells Engineered to Secrete Granulocyte-Macrophage Colony-stimulating Factor Using ex Vivo Gene Transfer1
Michael Carducci
2000
View PDFchevron_right
Allogeneic whole-tumour cell vaccination in the rat model of prostate cancer
David Hrouda, Stephen Todryk
BJU International, 2001
View PDFchevron_right
Immunotherapy for Prostate Cancer: Lessons from Responses to Tumor-Associated Antigens
Pierre Major
Frontiers in Immunology, 2014
View PDFchevron_right
Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes
Richard Barth
Cancer Immunology, Immunotherapy, 1996
View PDFchevron_right
Immunotherapy in prostate cancer: current state and future perspectives
Shokhi Goel
Therapeutic Advances in Urology, 2020
View PDFchevron_right
Prostate Stem Cell Antigen DNA Vaccination Breaks Tolerance to Self-antigen and Inhibits Prostate Cancer Growth
Sarfraz Ahmad
Molecular Therapy, 2009
View PDFchevron_right